It has been shown that BDNF, in addition to being involved in new neuroplastic and neuroadaptive modifications associated with substance use, also supports and maintains dopaminergic neurons in the midbrain and is involved in the modulation of dopamine release, contributing to the development of psychological dependencies in persons with opioid use disorder [31, 32]. The gene discussed is BDNF; the disease is opioid use disorder.